Rybelsus 7 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FC75Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,665
Award facts
- Contract value 100% obligated
- $20,664.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,664.54 to AmerisourceBergen Drug Corp for the supply of Rybelsus 7 mg tablets (30-count units). This firm fixed price, non-set-aside contract was executed on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Rybelsus is an oral semaglutide medication used primarily for glycemic control in patients with type 2 diabetes, representing routine pharmaceutical procurement for federal military and healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The parent IDC enables flexible procurement of specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to support military healthcare programs globally, with the DLA planning to establish multiple Pharmaceutical Prime Vendor Global Program Generation V contracts across separate regions in the coming years.
Quick answers
Who was awarded contract SPE2DB25FC75Q?
SPE2DB25FC75Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 14, 2025.
How much is contract SPE2DB25FC75Q worth?
The government has obligated $20,665 on SPE2DB25FC75Q.
Is contract SPE2DB25FC75Q an order under another contract?
Yes. SPE2DB25FC75Q is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FC75Q competed?
The extent of competition for SPE2DB25FC75Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award